Stocks/CLDX

Create a free account to see ACCE Scores

Sign up for free to unlock scores, score breakdowns, and stock analysis.

CLDX

↓ PDF (Pro)
Celldex Therapeutics Inc.
HealthcareBiotechnologyUnited StatesNASDAQ
$33.12
+1.05%today
MKT CAP
$2.7B
-0.2% · 1Y
Earnings History
-1.0%
-13.2%
-22.5%
-2.9%
Q2 '25
Q3 '25
Q4 '25
Q1 '26
Analyst Targets
Current price
$33.12
Low
$38.00
Analyst Mean
$57.50
High
$90.00
14 analystsStrong Buy
Full Financials
Trailing P/E-
Forward P/E-
EV/EBITDA-6.0x
Price/Sales-
Dividend Yield-
Revenue Growth YoY-89.7%
Earnings Growth YoY-
Revenue Growth QoQ-87.6%
5y Revenue CAGR-13.1%
5y Earnings CAGR-
Gross Margin0.0%
Operating Margin-72027.3%
Net Margin0.0%
ROE-40.6%
Debt / Equity0.44x
Free Cash Flow$-125,544,376
Insider Ownership0.3%
Institutional Ownership96.3%
Short % of Float12.57%
Days to Cover6.5d
1 Week-1.4%
1 Month-
3 Months-
6 Months-
YTD-
1 Year-
3 Years-
5 Years-
vs 50-day SMA-
vs 200-day SMA-
vs 52w High-
vs 52w Low-
Insider Transactions
FilerRoleTypeSharesPriceValueDate
MARTIN SAMUEL BATESChief Financial OfficerConversion4,817$10.38$0.05M2026-01-02
PEPIN RONALD AOfficerConversion19,333$2.78$0.11M2025-12-15
JIMENEZ FREDDY AGeneral CounselSale4,166$29.10$0.12M2025-12-04
WRIGHT RICHARD MFormerSale49,298$24.00$1.18M2025-11-13
WRIGHT RICHARD MFormerConversion49,298$9.02$0.69M2025-11-13
Top Holders
HolderType% HeldValueΔ SharesAs of
Wellington Management Group, LLPinstitution10.29%$0.27B+39.30%2025-12-31
Kynam Capital Management, LPinstitution7.57%$0.20B-2.58%2025-12-31
Blackrock Inc.institution6.95%$0.19B-0.98%2025-12-31
FMR, LLCinstitution6.25%$0.17B-1.10%2025-12-31
VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fundfund6.07%$0.16B+28.97%2026-01-31
Vanguard Group Incinstitution5.13%$0.14B+1.84%2025-12-31
Bellevue Group AGinstitution4.61%$0.12B+1.69%2025-12-31
State Street Corporationinstitution4.33%$0.12B+19.55%2025-12-31
Commodore Capital Lpinstitution3.27%$0.09B-15.30%2025-12-31
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fundfund2.69%$0.07B-1.92%2025-12-31
Price (T.Rowe) Associates Incinstitution2.60%$0.07B-14.39%2025-12-31
Deep Track Capital, Lpinstitution2.42%$0.06B-4.96%2025-12-31
iShares Trust-iShares Russell 2000 ETFfund2.02%$0.05B+0.29%2026-03-31
SPDR SERIES TRUST-State Street SPDR S&P Biotech ETFfund1.63%$0.04B-33.19%2026-03-31
Vanguard Explorer Fundfund1.35%$0.04B+0.00%2026-01-31
MUTUAL FUND SERIES TRUST-Eventide Healthcare & Life Sciences Fundfund1.32%$0.04B-23.54%2025-12-31
VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fundfund0.91%$0.02B+0.48%2025-12-31
Fidelity Salem Street Trust-Fidelity Small Cap Index Fundfund0.82%$0.02B+1.27%2026-02-28
MUTUAL FUND SERIES TRUST-Eventide Gilead Fundfund0.76%$0.02B+20.27%2025-12-31
iShares Trust-iShares Russell 2000 Value ETFfund0.71%$0.02B-0.30%2026-03-31
TickerCapScoreP/EFwd P/EEV/EBITDAROEGrossD/EDiv
PTGX
Protagonist Therapeutics Inc. Common Stock
$6.6B5------0.00%
CELC
Celcuity Inc. Common Stock
$6.7B5------0.00%
ACLX
Arcellx Inc. Common Stock
$6.7B5-------
KYMR
Kymera Therapeutics Inc. Common Stock
$7.0B-----27.1%0%5.230.00%
TECH
Bio-Techne Corp Common Stock
$7.1B3672.724.4----63.00%
HALO
Halozyme Therapeutics Inc. Common Stock
$7.9B7325.56.6----0.00%
Peers selected by sector + industry + nearest market cap. Best in column highlighted green, worst red.
Unlock Full Financials
Growth metrics, valuation multiples, and profitability ratios on Starter+.
Upgrade from $15/mo →
Recent Alerts
No alerts yet for CLDX.
Want deep analysis?
This stock isn't in the ACCE researched universe. Browse 300+ stocks with full thesis, scores, and financial models.
Browse ACCE Indices →
Get the ACCE weekly digest
Index returns, picks recap, score movers - every Sunday. No fluff.